279 related articles for article (PubMed ID: 30923657)
1. Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis.
Zhan Z; Chen Y; Duan Y; Li L; Mew K; Hu P; Ren H; Peng M
PeerJ; 2019; 7():e6645. PubMed ID: 30923657
[TBL] [Abstract][Full Text] [Related]
2. Microarray-Based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease: A Protein-Protein Interaction Network Analysis.
Mahmoudi A; Butler AE; De Vincentis A; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2023 May; ():. PubMed ID: 37194229
[TBL] [Abstract][Full Text] [Related]
3. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.
Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M
Nucleosides Nucleotides Nucleic Acids; 2024 Feb; ():1-16. PubMed ID: 38319987
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
Li LY; Wu JX
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532
[No Abstract] [Full Text] [Related]
5. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
6. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
PeerJ; 2018; 6():e5180. PubMed ID: 30002985
[TBL] [Abstract][Full Text] [Related]
7. Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis.
Sufyan M; Ali Ashfaq U; Ahmad S; Noor F; Hamzah Saleem M; Farhan Aslam M; El-Serehy HA; Aslam S
Saudi J Biol Sci; 2021 Oct; 28(10):5518-5525. PubMed ID: 34588861
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis.
Hou YP; Diao TT; Xu ZH; Mao XY; Wang C; Li B
Front Mol Biosci; 2021; 8():691966. PubMed ID: 35059432
[No Abstract] [Full Text] [Related]
9. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
10. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
Xing X; Xia Q; Gong B; Shen Z; Zhang Y
Front Genet; 2022; 13():855557. PubMed ID: 35368701
[No Abstract] [Full Text] [Related]
11. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
Li G; Cai L; Zhou L
Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
[TBL] [Abstract][Full Text] [Related]
12. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis.
Li Y; Yuan SL; Yin JY; Yang K; Zhou XG; Xie W; Wang Q
World J Gastrointest Oncol; 2022 Jul; 14(7):1265-1280. PubMed ID: 36051101
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
14. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
15. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
Zhang H; Huo J; Jiang W; Shan Q
Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
[TBL] [Abstract][Full Text] [Related]
16. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
17. Revealing immune infiltrate characteristics and potential immune-related genes in hepatic fibrosis: based on bioinformatics, transcriptomics and q-PCR experiments.
Bai YM; Liang S; Zhou B
Front Immunol; 2023; 14():1133543. PubMed ID: 37122694
[TBL] [Abstract][Full Text] [Related]
18. Identification of fibroblast activation-related genes in two acute kidney injury models.
Deng W; Wei X; Dong Z; Zhang J; Huang Z; Na N
PeerJ; 2021; 9():e10926. PubMed ID: 33777519
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis.
Ghatnatti V; Vastrad B; Patil S; Vastrad C; Kotturshetti I
AIMS Neurosci; 2021; 8(2):254-283. PubMed ID: 33709028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
